» Articles » PMID: 30723091

Dynamic Opioid Receptor Regulation in the Periphery

Overview
Journal Mol Pharmacol
Date 2019 Feb 7
PMID 30723091
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Opioids serve a vital role in the current analgesic array of treatment options. They are useful in acute instances involving severe pain associated with trauma, surgery, and terminal diseases such as cancer. In the past three decades, multiple receptor isoforms and conformations have been reported throughout literature. Most of these studies conducted systemic analyses of opioid receptor function, often generalizing findings from receptor systems in central nervous tissue or exogenously expressing immortalized cell lines as common mechanisms throughout physiology. However, a culmination of innovative experimental data indicates that opioid receptor systems are differentially modulated depending on their anatomic expression profile. Importantly, opioid receptors expressed in the peripheral nervous system undergo regulation uncommon to similar receptors expressed in central nervous system tissues. This distinctive characteristic begs one to question whether peripheral opioid receptors maintain anatomically unique roles, and whether they may serve an analgesic advantage in providing pain relief without promoting addiction.

Citing Articles

Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness.

Secondulfo C, Mazzeo F, Pastorino G, Vicidomini A, Meccariello R, Operto F Int J Mol Sci. 2024; 25(17).

PMID: 39273354 PMC: 11394805. DOI: 10.3390/ijms25179407.


Effects of pH on opioid receptor activation and implications for drug design.

Stein C Biophys J. 2024; 123(24):4158-4166.

PMID: 38970252 PMC: 11700362. DOI: 10.1016/j.bpj.2024.07.007.


Endogenous Opioids in Crohn's Disease.

Martyniak A, Wedrychowicz A, Tomasik P Biomedicines. 2023; 11(7).

PMID: 37509676 PMC: 10377721. DOI: 10.3390/biomedicines11072037.


Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP.

Celik M, Seitz V, Yergoz F, Dembla S, Blum N, Schulz S Front Mol Neurosci. 2023; 16:1171855.

PMID: 37251645 PMC: 10213447. DOI: 10.3389/fnmol.2023.1171855.


Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction.

Sadee W, McKew J Molecules. 2022; 27(18).

PMID: 36144565 PMC: 9503102. DOI: 10.3390/molecules27185826.


References
1.
Thal D, Homan K, Chen J, Wu E, Hinkle P, Huang Z . Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem Biol. 2012; 7(11):1830-9. PMC: 3500392. DOI: 10.1021/cb3003013. View

2.
Whistler J, von Zastrow M . Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci U S A. 1998; 95(17):9914-9. PMC: 21436. DOI: 10.1073/pnas.95.17.9914. View

3.
Walwyn W, John S, Maga M, Evans C, Hales T . Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol. 2009; 76(1):134-43. PMC: 2701458. DOI: 10.1124/mol.109.055913. View

4.
Appleyard S, Patterson T, Jin W, Chavkin C . Agonist-induced phosphorylation of the kappa-opioid receptor. J Neurochem. 1997; 69(6):2405-12. DOI: 10.1046/j.1471-4159.1997.69062405.x. View

5.
Thal D, Yeow R, Schoenau C, Huber J, Tesmer J . Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol Pharmacol. 2011; 80(2):294-303. PMC: 3141885. DOI: 10.1124/mol.111.071522. View